- Home
- / Scandidos
Scandidos
Revenue
KR61.8 M
FY, 2025
Scandidos Summary
Company Summary
- Overview
- ScandiDos is a QA and Dosimetry for modern radiation therapy. It offers unique measurement systems and software that are designed for QA and validation of new dynamic and modulated treatments that are being implemented in clinics. The company also provides Delta4 Family of products for QA of advanced radiation therapy procedures such as RapidArc, VMAT, IMRT and Tomotherapy.
- Type
- Public
- Status
- Active
- Founded
- 2002
- HQ
- Uppsala, SE | view all locations
- Website
- https://scandidos.com
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
4 locations detected
Uppsala, Uppsala län HQ
Sweden
Dag Hammarskjölds Väg 52A
Verona, WI
United States
Beijing, Beijing
China
Paris, IDF
France
59 Rue des Petits Champs
Scandidos Financials
Summary Financials
- Revenue (Q3, 2026)
- kr13.7M
- Gross profit (Q3, 2026)
- kr10.2M
- Net income (Q3, 2026)
- (kr1.7M)
- Cash (Q3, 2026)
- kr5.9M
- EBIT (Q3, 2026)
- (kr1.3M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026